ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Enteric Coated Softgels For Consumer Health Spplements Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-13R17236
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Enteric Coated Softgels For Consumer Health Spplements Market Research Report 2024
BUY CHAPTERS

Global Enteric Coated Softgels For Consumer Health Spplements Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-13R17236
Report
November 2025
Pages:141
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Aenova Group
CAPTEK Softgel International Inc.
Gelita
Procaps Group
InovoBiologic
Catalent
Sirio Pharma Co., Ltd
NOW foods Inc
Lonza Group Ltd
BASF SE
Viva Pharmaceuticals
Fuji Capsules Co. Ltd
Renown Pharmaceuticals Pvt. Ltd.

Enteric Coated Softgels For Consumer Health Spplements Market Size

The global Enteric Coated Softgels For Consumer Health Spplements market is projected to grow from US$ 1901 million in 2024 to US$ 2492 million by 2031, at a CAGR of 4.0% (2025-2031), driven by critical product segments and diverse end‑use applications.

Enteric Coated Softgels For Consumer Health Spplements Market

Enteric Coated Softgels For Consumer Health Spplements Market

An enteric softgel capsule is an oral drug delivery system encapsulated in a gelatin-based shell designed to release its contents in the small intestine rather than the stomach. The gelatin shell, which may include glycerin and plasticizers, is flexible and easy to swallow. This specific formulation prevents the premature release of the encapsulated substance, making it suitable for drugs or supplements sensitive to gastric acids. Enteric softgel capsules are commonly utilized in the pharmaceutical and nutraceutical industries, offering benefits such as enhanced drug absorption, reduced gastrointestinal side effects, and improved patient compliance, especially for individuals with specific health considerations.
The enteric softgel capsules industry is experiencing growth propelled by technological advancements in manufacturing. Ongoing innovations enhance the efficiency and precision of softgel capsule production, contributing to improved quality and cost-effectiveness. Key industry players are actively focusing on developing advanced manufacturing methodologies, emphasizing automation and novel techniques. For instance, Catalent, Inc, offers OptiGel DR Softgel Technology, that has the capability to deliver an enteric release profile in a single-step manufacturing process without the need for coating. This commitment to technological progress not only boosts production capabilities but also ensures a competitive edge in the market. The growing synergy between technological advancements and the strategic initiatives of key players underscores a positive trajectory for the enteric softgel capsule market, fostering increased reliability and innovation in the manufacturing process. In addition, the enteric softgel capsules industry is experiencing additional growth due to the increasing focus on clinical trials for new technologies and formulations. For instance, in October 2023, Evonik, a specialty chemicals leader, introduced EUDRACAP, a preclinical functional oral capsule. This enteric-coated capsule offers pharmaceutical companies a valuable tool in optimizing drug development during preclinical trials. By reducing costs, time, and variables, EUDRACAP enhances the efficiency of drug development processes. This innovative approach aligns with the industry's commitment to advancing methodologies, fostering a climate of continuous improvement and driving the market's growth through enhanced capabilities in clinical research and development.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Enteric Coated Softgels For Consumer Health Spplements market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Enteric Coated Softgels For Consumer Health Spplements Market Report

Report Metric Details
Report Name Enteric Coated Softgels For Consumer Health Spplements Market
Accounted market size in 2024 US$ 1901 million
Forecasted market size in 2031 US$ 2492 million
CAGR 4.0%
Base Year 2024
Forecasted years 2025 - 2031
Segment by Type
  • Type-A Gelatin (Pork Skin)
  • Type-B Gelatin (Animal Bones & Skin)
  • Starch Material
  • Others
Segment by Application
  • Online
  • Offline
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Viva Pharmaceuticals, Fuji Capsules Co. Ltd, Aenova Group, Captek Softgel International Inc, Gelita AG, Procaps Group, InovoBiologic Inc, Catalent, Inc, Sirio Pharma Co., Ltd, NOW Foods Inc., Renown Pharmaceuticals Pvt. Ltd., Lonza Group Ltd, Basf SE
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Enteric Coated Softgels For Consumer Health Spplements study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Enteric Coated Softgels For Consumer Health Spplements Market growing?

Ans: The Enteric Coated Softgels For Consumer Health Spplements Market witnessing a CAGR of 4.0% during the forecast period 2025-2031.

What is the Enteric Coated Softgels For Consumer Health Spplements Market size in 2031?

Ans: The Enteric Coated Softgels For Consumer Health Spplements Market size in 2031 will be US$ 2492 million.

Who are the main players in the Enteric Coated Softgels For Consumer Health Spplements Market report?

Ans: The main players in the Enteric Coated Softgels For Consumer Health Spplements Market are Viva Pharmaceuticals, Fuji Capsules Co. Ltd, Aenova Group, Captek Softgel International Inc, Gelita AG, Procaps Group, InovoBiologic Inc, Catalent, Inc, Sirio Pharma Co., Ltd, NOW Foods Inc., Renown Pharmaceuticals Pvt. Ltd., Lonza Group Ltd, Basf SE

What are the Application segmentation covered in the Enteric Coated Softgels For Consumer Health Spplements Market report?

Ans: The Applications covered in the Enteric Coated Softgels For Consumer Health Spplements Market report are Online, Offline

What are the Type segmentation covered in the Enteric Coated Softgels For Consumer Health Spplements Market report?

Ans: The Types covered in the Enteric Coated Softgels For Consumer Health Spplements Market report are Type-A Gelatin (Pork Skin), Type-B Gelatin (Animal Bones & Skin), Starch Material, Others

1 Study Coverage
1.1 Introduction to Enteric Coated Softgels For Consumer Health Spplements: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Enteric Coated Softgels For Consumer Health Spplements Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Type-A Gelatin (Pork Skin)
1.2.3 Type-B Gelatin (Animal Bones & Skin)
1.2.4 Starch Material
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Enteric Coated Softgels For Consumer Health Spplements Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Online
1.3.3 Offline
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Enteric Coated Softgels For Consumer Health Spplements Revenue Estimates and Forecasts 2020-2031
2.2 Global Enteric Coated Softgels For Consumer Health Spplements Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Enteric Coated Softgels For Consumer Health Spplements Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Enteric Coated Softgels For Consumer Health Spplements Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Type-A Gelatin (Pork Skin) Market Size by Players
3.3.2 Type-B Gelatin (Animal Bones & Skin) Market Size by Players
3.3.3 Starch Material Market Size by Players
3.3.4 Others Market Size by Players
3.4 Global Enteric Coated Softgels For Consumer Health Spplements Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Enteric Coated Softgels For Consumer Health Spplements Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Enteric Coated Softgels For Consumer Health Spplements Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Enteric Coated Softgels For Consumer Health Spplements Market Size by Type (2020-2031)
6.4 North America Enteric Coated Softgels For Consumer Health Spplements Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Enteric Coated Softgels For Consumer Health Spplements Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Enteric Coated Softgels For Consumer Health Spplements Market Size by Type (2020-2031)
7.4 Europe Enteric Coated Softgels For Consumer Health Spplements Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Enteric Coated Softgels For Consumer Health Spplements Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Enteric Coated Softgels For Consumer Health Spplements Market Size by Type (2020-2031)
8.4 Asia-Pacific Enteric Coated Softgels For Consumer Health Spplements Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Enteric Coated Softgels For Consumer Health Spplements Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Enteric Coated Softgels For Consumer Health Spplements Market Size by Type (2020-2031)
9.4 Central and South America Enteric Coated Softgels For Consumer Health Spplements Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Enteric Coated Softgels For Consumer Health Spplements Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Enteric Coated Softgels For Consumer Health Spplements Market Size by Type (2020-2031)
10.4 Middle East and Africa Enteric Coated Softgels For Consumer Health Spplements Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Enteric Coated Softgels For Consumer Health Spplements Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Viva Pharmaceuticals
11.1.1 Viva Pharmaceuticals Corporation Information
11.1.2 Viva Pharmaceuticals Business Overview
11.1.3 Viva Pharmaceuticals Enteric Coated Softgels For Consumer Health Spplements Product Features and Attributes
11.1.4 Viva Pharmaceuticals Enteric Coated Softgels For Consumer Health Spplements Revenue and Gross Margin (2020-2025)
11.1.5 Viva Pharmaceuticals Enteric Coated Softgels For Consumer Health Spplements Revenue by Product in 2024
11.1.6 Viva Pharmaceuticals Enteric Coated Softgels For Consumer Health Spplements Revenue by Application in 2024
11.1.7 Viva Pharmaceuticals Enteric Coated Softgels For Consumer Health Spplements Revenue by Geographic Area in 2024
11.1.8 Viva Pharmaceuticals Enteric Coated Softgels For Consumer Health Spplements SWOT Analysis
11.1.9 Viva Pharmaceuticals Recent Developments
11.2 Fuji Capsules Co. Ltd
11.2.1 Fuji Capsules Co. Ltd Corporation Information
11.2.2 Fuji Capsules Co. Ltd Business Overview
11.2.3 Fuji Capsules Co. Ltd Enteric Coated Softgels For Consumer Health Spplements Product Features and Attributes
11.2.4 Fuji Capsules Co. Ltd Enteric Coated Softgels For Consumer Health Spplements Revenue and Gross Margin (2020-2025)
11.2.5 Fuji Capsules Co. Ltd Enteric Coated Softgels For Consumer Health Spplements Revenue by Product in 2024
11.2.6 Fuji Capsules Co. Ltd Enteric Coated Softgels For Consumer Health Spplements Revenue by Application in 2024
11.2.7 Fuji Capsules Co. Ltd Enteric Coated Softgels For Consumer Health Spplements Revenue by Geographic Area in 2024
11.2.8 Fuji Capsules Co. Ltd Enteric Coated Softgels For Consumer Health Spplements SWOT Analysis
11.2.9 Fuji Capsules Co. Ltd Recent Developments
11.3 Aenova Group
11.3.1 Aenova Group Corporation Information
11.3.2 Aenova Group Business Overview
11.3.3 Aenova Group Enteric Coated Softgels For Consumer Health Spplements Product Features and Attributes
11.3.4 Aenova Group Enteric Coated Softgels For Consumer Health Spplements Revenue and Gross Margin (2020-2025)
11.3.5 Aenova Group Enteric Coated Softgels For Consumer Health Spplements Revenue by Product in 2024
11.3.6 Aenova Group Enteric Coated Softgels For Consumer Health Spplements Revenue by Application in 2024
11.3.7 Aenova Group Enteric Coated Softgels For Consumer Health Spplements Revenue by Geographic Area in 2024
11.3.8 Aenova Group Enteric Coated Softgels For Consumer Health Spplements SWOT Analysis
11.3.9 Aenova Group Recent Developments
11.4 Captek Softgel International Inc
11.4.1 Captek Softgel International Inc Corporation Information
11.4.2 Captek Softgel International Inc Business Overview
11.4.3 Captek Softgel International Inc Enteric Coated Softgels For Consumer Health Spplements Product Features and Attributes
11.4.4 Captek Softgel International Inc Enteric Coated Softgels For Consumer Health Spplements Revenue and Gross Margin (2020-2025)
11.4.5 Captek Softgel International Inc Enteric Coated Softgels For Consumer Health Spplements Revenue by Product in 2024
11.4.6 Captek Softgel International Inc Enteric Coated Softgels For Consumer Health Spplements Revenue by Application in 2024
11.4.7 Captek Softgel International Inc Enteric Coated Softgels For Consumer Health Spplements Revenue by Geographic Area in 2024
11.4.8 Captek Softgel International Inc Enteric Coated Softgels For Consumer Health Spplements SWOT Analysis
11.4.9 Captek Softgel International Inc Recent Developments
11.5 Gelita AG
11.5.1 Gelita AG Corporation Information
11.5.2 Gelita AG Business Overview
11.5.3 Gelita AG Enteric Coated Softgels For Consumer Health Spplements Product Features and Attributes
11.5.4 Gelita AG Enteric Coated Softgels For Consumer Health Spplements Revenue and Gross Margin (2020-2025)
11.5.5 Gelita AG Enteric Coated Softgels For Consumer Health Spplements Revenue by Product in 2024
11.5.6 Gelita AG Enteric Coated Softgels For Consumer Health Spplements Revenue by Application in 2024
11.5.7 Gelita AG Enteric Coated Softgels For Consumer Health Spplements Revenue by Geographic Area in 2024
11.5.8 Gelita AG Enteric Coated Softgels For Consumer Health Spplements SWOT Analysis
11.5.9 Gelita AG Recent Developments
11.6 Procaps Group
11.6.1 Procaps Group Corporation Information
11.6.2 Procaps Group Business Overview
11.6.3 Procaps Group Enteric Coated Softgels For Consumer Health Spplements Product Features and Attributes
11.6.4 Procaps Group Enteric Coated Softgels For Consumer Health Spplements Revenue and Gross Margin (2020-2025)
11.6.5 Procaps Group Recent Developments
11.7 InovoBiologic Inc
11.7.1 InovoBiologic Inc Corporation Information
11.7.2 InovoBiologic Inc Business Overview
11.7.3 InovoBiologic Inc Enteric Coated Softgels For Consumer Health Spplements Product Features and Attributes
11.7.4 InovoBiologic Inc Enteric Coated Softgels For Consumer Health Spplements Revenue and Gross Margin (2020-2025)
11.7.5 InovoBiologic Inc Recent Developments
11.8 Catalent, Inc
11.8.1 Catalent, Inc Corporation Information
11.8.2 Catalent, Inc Business Overview
11.8.3 Catalent, Inc Enteric Coated Softgels For Consumer Health Spplements Product Features and Attributes
11.8.4 Catalent, Inc Enteric Coated Softgels For Consumer Health Spplements Revenue and Gross Margin (2020-2025)
11.8.5 Catalent, Inc Recent Developments
11.9 Sirio Pharma Co., Ltd
11.9.1 Sirio Pharma Co., Ltd Corporation Information
11.9.2 Sirio Pharma Co., Ltd Business Overview
11.9.3 Sirio Pharma Co., Ltd Enteric Coated Softgels For Consumer Health Spplements Product Features and Attributes
11.9.4 Sirio Pharma Co., Ltd Enteric Coated Softgels For Consumer Health Spplements Revenue and Gross Margin (2020-2025)
11.9.5 Sirio Pharma Co., Ltd Recent Developments
11.10 NOW Foods Inc.
11.10.1 NOW Foods Inc. Corporation Information
11.10.2 NOW Foods Inc. Business Overview
11.10.3 NOW Foods Inc. Enteric Coated Softgels For Consumer Health Spplements Product Features and Attributes
11.10.4 NOW Foods Inc. Enteric Coated Softgels For Consumer Health Spplements Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Renown Pharmaceuticals Pvt. Ltd.
11.11.1 Renown Pharmaceuticals Pvt. Ltd. Corporation Information
11.11.2 Renown Pharmaceuticals Pvt. Ltd. Business Overview
11.11.3 Renown Pharmaceuticals Pvt. Ltd. Enteric Coated Softgels For Consumer Health Spplements Product Features and Attributes
11.11.4 Renown Pharmaceuticals Pvt. Ltd. Enteric Coated Softgels For Consumer Health Spplements Revenue and Gross Margin (2020-2025)
11.11.5 Renown Pharmaceuticals Pvt. Ltd. Recent Developments
11.12 Lonza Group Ltd
11.12.1 Lonza Group Ltd Corporation Information
11.12.2 Lonza Group Ltd Business Overview
11.12.3 Lonza Group Ltd Enteric Coated Softgels For Consumer Health Spplements Product Features and Attributes
11.12.4 Lonza Group Ltd Enteric Coated Softgels For Consumer Health Spplements Revenue and Gross Margin (2020-2025)
11.12.5 Lonza Group Ltd Recent Developments
11.13 Basf SE
11.13.1 Basf SE Corporation Information
11.13.2 Basf SE Business Overview
11.13.3 Basf SE Enteric Coated Softgels For Consumer Health Spplements Product Features and Attributes
11.13.4 Basf SE Enteric Coated Softgels For Consumer Health Spplements Revenue and Gross Margin (2020-2025)
11.13.5 Basf SE Recent Developments
12 Enteric Coated Softgels For Consumer Health SpplementsIndustry Chain Analysis
12.1 Enteric Coated Softgels For Consumer Health Spplements Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Enteric Coated Softgels For Consumer Health Spplements Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Enteric Coated Softgels For Consumer Health Spplements Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Aenova Group
CAPTEK Softgel International Inc.
Gelita
Procaps Group
InovoBiologic
Catalent
Sirio Pharma Co., Ltd
NOW foods Inc
Lonza Group Ltd
BASF SE
Viva Pharmaceuticals
Fuji Capsules Co. Ltd
Renown Pharmaceuticals Pvt. Ltd.
List of Tables
 Table 1. Global Enteric Coated Softgels For Consumer Health Spplements Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Enteric Coated Softgels For Consumer Health Spplements Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Enteric Coated Softgels For Consumer Health Spplements Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Enteric Coated Softgels For Consumer Health Spplements Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Enteric Coated Softgels For Consumer Health Spplements Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Enteric Coated Softgels For Consumer Health Spplements Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Enteric Coated Softgels For Consumer Health Spplements Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Enteric Coated Softgels For Consumer Health Spplements by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enteric Coated Softgels For Consumer Health Spplements as of 2024)
 Table 11. Global Enteric Coated Softgels For Consumer Health Spplements Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Enteric Coated Softgels For Consumer Health Spplements Companies Headquarters
 Table 13. Global Enteric Coated Softgels For Consumer Health Spplements Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Enteric Coated Softgels For Consumer Health Spplements Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Enteric Coated Softgels For Consumer Health Spplements Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Enteric Coated Softgels For Consumer Health Spplements Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Enteric Coated Softgels For Consumer Health Spplements Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Enteric Coated Softgels For Consumer Health Spplements High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Enteric Coated Softgels For Consumer Health Spplements Growth Accelerators and Market Barriers
 Table 25. North America Enteric Coated Softgels For Consumer Health Spplements Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Enteric Coated Softgels For Consumer Health Spplements Growth Accelerators and Market Barriers
 Table 27. Europe Enteric Coated Softgels For Consumer Health Spplements Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Enteric Coated Softgels For Consumer Health Spplements Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Enteric Coated Softgels For Consumer Health Spplements Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Enteric Coated Softgels For Consumer Health Spplements Investment Opportunities and Key Challenges
 Table 31. Central and South America Enteric Coated Softgels For Consumer Health Spplements Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Enteric Coated Softgels For Consumer Health Spplements Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Enteric Coated Softgels For Consumer Health Spplements Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Viva Pharmaceuticals Corporation Information
 Table 35. Viva Pharmaceuticals Description and Major Businesses
 Table 36. Viva Pharmaceuticals Product Features and Attributes
 Table 37. Viva Pharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Viva Pharmaceuticals Revenue Proportion by Product in 2024
 Table 39. Viva Pharmaceuticals Revenue Proportion by Application in 2024
 Table 40. Viva Pharmaceuticals Revenue Proportion by Geographic Area in 2024
 Table 41. Viva Pharmaceuticals Enteric Coated Softgels For Consumer Health Spplements SWOT Analysis
 Table 42. Viva Pharmaceuticals Recent Developments
 Table 43. Fuji Capsules Co. Ltd Corporation Information
 Table 44. Fuji Capsules Co. Ltd Description and Major Businesses
 Table 45. Fuji Capsules Co. Ltd Product Features and Attributes
 Table 46. Fuji Capsules Co. Ltd Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Fuji Capsules Co. Ltd Revenue Proportion by Product in 2024
 Table 48. Fuji Capsules Co. Ltd Revenue Proportion by Application in 2024
 Table 49. Fuji Capsules Co. Ltd Revenue Proportion by Geographic Area in 2024
 Table 50. Fuji Capsules Co. Ltd Enteric Coated Softgels For Consumer Health Spplements SWOT Analysis
 Table 51. Fuji Capsules Co. Ltd Recent Developments
 Table 52. Aenova Group Corporation Information
 Table 53. Aenova Group Description and Major Businesses
 Table 54. Aenova Group Product Features and Attributes
 Table 55. Aenova Group Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Aenova Group Revenue Proportion by Product in 2024
 Table 57. Aenova Group Revenue Proportion by Application in 2024
 Table 58. Aenova Group Revenue Proportion by Geographic Area in 2024
 Table 59. Aenova Group Enteric Coated Softgels For Consumer Health Spplements SWOT Analysis
 Table 60. Aenova Group Recent Developments
 Table 61. Captek Softgel International Inc Corporation Information
 Table 62. Captek Softgel International Inc Description and Major Businesses
 Table 63. Captek Softgel International Inc Product Features and Attributes
 Table 64. Captek Softgel International Inc Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Captek Softgel International Inc Revenue Proportion by Product in 2024
 Table 66. Captek Softgel International Inc Revenue Proportion by Application in 2024
 Table 67. Captek Softgel International Inc Revenue Proportion by Geographic Area in 2024
 Table 68. Captek Softgel International Inc Enteric Coated Softgels For Consumer Health Spplements SWOT Analysis
 Table 69. Captek Softgel International Inc Recent Developments
 Table 70. Gelita AG Corporation Information
 Table 71. Gelita AG Description and Major Businesses
 Table 72. Gelita AG Product Features and Attributes
 Table 73. Gelita AG Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Gelita AG Revenue Proportion by Product in 2024
 Table 75. Gelita AG Revenue Proportion by Application in 2024
 Table 76. Gelita AG Revenue Proportion by Geographic Area in 2024
 Table 77. Gelita AG Enteric Coated Softgels For Consumer Health Spplements SWOT Analysis
 Table 78. Gelita AG Recent Developments
 Table 79. Procaps Group Corporation Information
 Table 80. Procaps Group Description and Major Businesses
 Table 81. Procaps Group Product Features and Attributes
 Table 82. Procaps Group Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Procaps Group Recent Developments
 Table 84. InovoBiologic Inc Corporation Information
 Table 85. InovoBiologic Inc Description and Major Businesses
 Table 86. InovoBiologic Inc Product Features and Attributes
 Table 87. InovoBiologic Inc Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. InovoBiologic Inc Recent Developments
 Table 89. Catalent, Inc Corporation Information
 Table 90. Catalent, Inc Description and Major Businesses
 Table 91. Catalent, Inc Product Features and Attributes
 Table 92. Catalent, Inc Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Catalent, Inc Recent Developments
 Table 94. Sirio Pharma Co., Ltd Corporation Information
 Table 95. Sirio Pharma Co., Ltd Description and Major Businesses
 Table 96. Sirio Pharma Co., Ltd Product Features and Attributes
 Table 97. Sirio Pharma Co., Ltd Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Sirio Pharma Co., Ltd Recent Developments
 Table 99. NOW Foods Inc. Corporation Information
 Table 100. NOW Foods Inc. Description and Major Businesses
 Table 101. NOW Foods Inc. Product Features and Attributes
 Table 102. NOW Foods Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. NOW Foods Inc. Recent Developments
 Table 104. Renown Pharmaceuticals Pvt. Ltd. Corporation Information
 Table 105. Renown Pharmaceuticals Pvt. Ltd. Description and Major Businesses
 Table 106. Renown Pharmaceuticals Pvt. Ltd. Product Features and Attributes
 Table 107. Renown Pharmaceuticals Pvt. Ltd. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Renown Pharmaceuticals Pvt. Ltd. Recent Developments
 Table 109. Lonza Group Ltd Corporation Information
 Table 110. Lonza Group Ltd Description and Major Businesses
 Table 111. Lonza Group Ltd Product Features and Attributes
 Table 112. Lonza Group Ltd Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Lonza Group Ltd Recent Developments
 Table 114. Basf SE Corporation Information
 Table 115. Basf SE Description and Major Businesses
 Table 116. Basf SE Product Features and Attributes
 Table 117. Basf SE Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. Basf SE Recent Developments
 Table 119. Raw Materials Key Suppliers
 Table 120. Distributors List
 Table 121. Market Trends and Market Evolution
 Table 122. Market Drivers and Opportunities
 Table 123. Market Challenges, Risks, and Restraints
 Table 124. Research Programs/Design for This Report
 Table 125. Key Data Information from Secondary Sources
 Table 126. Key Data Information from Primary Sources


List of Figures
 Figure 1. Enteric Coated Softgels For Consumer Health Spplements Product Picture
 Figure 2. Global Enteric Coated Softgels For Consumer Health Spplements Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Type-A Gelatin (Pork Skin) Product Picture
 Figure 4. Type-B Gelatin (Animal Bones & Skin) Product Picture
 Figure 5. Starch Material Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Enteric Coated Softgels For Consumer Health Spplements Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Online
 Figure 9. Offline
 Figure 10. Enteric Coated Softgels For Consumer Health Spplements Report Years Considered
 Figure 11. Global Enteric Coated Softgels For Consumer Health Spplements Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Enteric Coated Softgels For Consumer Health Spplements Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Enteric Coated Softgels For Consumer Health Spplements Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Enteric Coated Softgels For Consumer Health Spplements Revenue Market Share by Region (2020-2031)
 Figure 15. Global Enteric Coated Softgels For Consumer Health Spplements Revenue Market Share Ranking (2024)
 Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 17. Type-A Gelatin (Pork Skin) Revenue Market Share by Player in 2024
 Figure 18. Type-B Gelatin (Animal Bones & Skin) Revenue Market Share by Player in 2024
 Figure 19. Starch Material Revenue Market Share by Player in 2024
 Figure 20. Others Revenue Market Share by Player in 2024
 Figure 21. Global Enteric Coated Softgels For Consumer Health Spplements Revenue Market Share by Type (2020-2031)
 Figure 22. Global Enteric Coated Softgels For Consumer Health Spplements Revenue Market Share by Application (2020-2031)
 Figure 23. North America Enteric Coated Softgels For Consumer Health Spplements Revenue YoY (2020-2031) & (US$ Million)
 Figure 24. North America Top 5 Players Enteric Coated Softgels For Consumer Health Spplements Revenue (US$ Million) in 2024
 Figure 25. North America Enteric Coated Softgels For Consumer Health Spplements Revenue (US$ Million) by Type (2020 - 2031)
 Figure 26. North America Enteric Coated Softgels For Consumer Health Spplements Revenue (US$ Million) by Application (2020-2031)
 Figure 27. US Enteric Coated Softgels For Consumer Health Spplements Revenue (2020-2031) & (US$ Million)
 Figure 28. Canada Enteric Coated Softgels For Consumer Health Spplements Revenue (2020-2031) & (US$ Million)
 Figure 29. Mexico Enteric Coated Softgels For Consumer Health Spplements Revenue (2020-2031) & (US$ Million)
 Figure 30. Europe Enteric Coated Softgels For Consumer Health Spplements Revenue YoY (2020-2031) & (US$ Million)
 Figure 31. Europe Top 5 Players Enteric Coated Softgels For Consumer Health Spplements Revenue (US$ Million) in 2024
 Figure 32. Europe Enteric Coated Softgels For Consumer Health Spplements Revenue (US$ Million) by Type (2020-2031)
 Figure 33. Europe Enteric Coated Softgels For Consumer Health Spplements Revenue (US$ Million) by Application (2020-2031)
 Figure 34. Germany Enteric Coated Softgels For Consumer Health Spplements Revenue (2020-2031) & (US$ Million)
 Figure 35. France Enteric Coated Softgels For Consumer Health Spplements Revenue (2020-2031) & (US$ Million)
 Figure 36. U.K. Enteric Coated Softgels For Consumer Health Spplements Revenue (2020-2031) & (US$ Million)
 Figure 37. Italy Enteric Coated Softgels For Consumer Health Spplements Revenue (2020-2031) & (US$ Million)
 Figure 38. Russia Enteric Coated Softgels For Consumer Health Spplements Revenue (2020-2031) & (US$ Million)
 Figure 39. Asia-Pacific Enteric Coated Softgels For Consumer Health Spplements Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. Asia-Pacific Top 8 Players Enteric Coated Softgels For Consumer Health Spplements Revenue (US$ Million) in 2024
 Figure 41. Asia-Pacific Enteric Coated Softgels For Consumer Health Spplements Revenue (US$ Million) by Type (2020-2031)
 Figure 42. Asia-Pacific Enteric Coated Softgels For Consumer Health Spplements Revenue (US$ Million) by Application (2020-2031)
 Figure 43. Indonesia Enteric Coated Softgels For Consumer Health Spplements Revenue (2020-2031) & (US$ Million)
 Figure 44. Japan Enteric Coated Softgels For Consumer Health Spplements Revenue (2020-2031) & (US$ Million)
 Figure 45. South Korea Enteric Coated Softgels For Consumer Health Spplements Revenue (2020-2031) & (US$ Million)
 Figure 46. Australia Enteric Coated Softgels For Consumer Health Spplements Revenue (2020-2031) & (US$ Million)
 Figure 47. India Enteric Coated Softgels For Consumer Health Spplements Revenue (2020-2031) & (US$ Million)
 Figure 48. Indonesia Enteric Coated Softgels For Consumer Health Spplements Revenue (2020-2031) & (US$ Million)
 Figure 49. Vietnam Enteric Coated Softgels For Consumer Health Spplements Revenue (2020-2031) & (US$ Million)
 Figure 50. Malaysia Enteric Coated Softgels For Consumer Health Spplements Revenue (2020-2031) & (US$ Million)
 Figure 51. Philippines Enteric Coated Softgels For Consumer Health Spplements Revenue (2020-2031) & (US$ Million)
 Figure 52. Singapore Enteric Coated Softgels For Consumer Health Spplements Revenue (2020-2031) & (US$ Million)
 Figure 53. Central and South America Enteric Coated Softgels For Consumer Health Spplements Revenue YoY (2020-2031) & (US$ Million)
 Figure 54. Central and South America Top 5 Players Enteric Coated Softgels For Consumer Health Spplements Revenue (US$ Million) in 2024
 Figure 55. Central and South America Enteric Coated Softgels For Consumer Health Spplements Revenue (US$ Million) by Type (2020-2031)
 Figure 56. Central and South America Enteric Coated Softgels For Consumer Health Spplements Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Brazil Enteric Coated Softgels For Consumer Health Spplements Revenue (2020-2025) & (US$ Million)
 Figure 58. Argentina Enteric Coated Softgels For Consumer Health Spplements Revenue (2020-2025) & (US$ Million)
 Figure 59. Middle East and Africa Enteric Coated Softgels For Consumer Health Spplements Revenue YoY (2020-2031) & (US$ Million)
 Figure 60. Middle East and Africa Top 5 Players Enteric Coated Softgels For Consumer Health Spplements Revenue (US$ Million) in 2024
 Figure 61. South America Enteric Coated Softgels For Consumer Health Spplements Revenue (US$ Million) by Type (2020-2031)
 Figure 62. Middle East and Africa Enteric Coated Softgels For Consumer Health Spplements Revenue (US$ Million) by Application (2020-2031)
 Figure 63. GCC Countries Enteric Coated Softgels For Consumer Health Spplements Revenue (2020-2025) & (US$ Million)
 Figure 64. Israel Enteric Coated Softgels For Consumer Health Spplements Revenue (2020-2025) & (US$ Million)
 Figure 65. Egypt Enteric Coated Softgels For Consumer Health Spplements Revenue (2020-2025) & (US$ Million)
 Figure 66. South Africa Enteric Coated Softgels For Consumer Health Spplements Revenue (2020-2025) & (US$ Million)
 Figure 67. Enteric Coated Softgels For Consumer Health Spplements Industry Chain Mapping
 Figure 68. Channels of Distribution (Direct Vs Distribution)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Bio Reactors and Fermentors Market Research Report 2024
Global Health Supplements Softgel Capsules Market Research Report 2024
Soft Gel Capsule Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Plant Enteric Coated Hollow Capsules Market Research Report 2024
Global Softgel Encapsulation System Market Research Report 2025
Medicinal Gelatin Soft Capsules Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Soft Capsules Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Soft Capsules Market Research Report 2024
Global Soft Gelatin Capsules Market Research Report 2024
Global Soft Gelatin Capsules Softgels Market Insights Forecast to 2030
Global Enteric Gelatin Hollow Capsule Market Research Report 2025
Global Automatic Soft Capsule Encapsulation System Market Research Report 2024
Softgel Capsule Machinery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gelatin Based Capsules Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Softgel Capsules for Supplements Market Research Report 2025
Global Enteric coated HPMC Capsules Market Research Report 2024
Global Softgel Manufacturing Equipment Market Research Report 2025
Easy Chewable Softgels Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gel Capsule Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Enteric Film Coating Agent Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions